New injectable filler aims to restore facial fullness without surgery
NCT ID NCT06034522
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a new injectable filler called Adipearl for people with mid-face volume loss (hollow cheeks). The trial involves 18 adults aged 22 to 65 and focuses on safety and how well the procedure works. Researchers will monitor injection site reactions and other side effects over the study period.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Adipearl (injectable filler)
- What this could lead to
- If successful, this could lead to a new option for restoring facial volume without surgery.
- What could go wrong
- This is a very small, early-stage trial focused only on safety and feasibility, not on effectiveness. The filler may not work as hoped or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MID-FACE VOLUME DEFICIENCY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Art Clinic
Stockholm, Sweden